Inhibition of AXL along with c-Met overcomes resistance development in renal cell carcinoma
Date:
Poster on dual AXL and c-Met inhibition as a strategy to overcome therapeutic resistance in RCC.
Marc Machaalani, MD
Postdoctoral Research Fellow
- Boston, MA
- Dana-Farber Cancer Institute
- Google Scholar
- ORCID
- PubMed
- ResearchGate
- X (formerly Twitter)